{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:11:33Z","timestamp":1791573093141,"version":"4.3.4"},"reference-count":50,"publisher":"PeerJ","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Hebei Province 2024 Annual Medical Scientific Research Project Plan","award":["20240450"],"award-info":[{"award-number":["20240450"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Clear cell renal cell carcinoma (ccRCC) is a prevalent pathological subtype of renal cell carcinoma that arises from renal tubular epithelial cells. ccRCC has long been characterized by high mortality, and at present, surgical resection is the only curative treatment, but its effectiveness is low and survival rates are low. N-acetyltransferase 10 (NAT10) is a protein that acts as an acetyltransferase, has distinct catalytic and regulatory functions, and is involved in the progression of various cancers such as bladder cancer, hepatocellular carcinoma, and multiple myeloma. Ferroptosis is a novel form of programmed cell death that is iron-dependent and distinct from apoptosis, necrosis, and autophagy. Therefore, this study aimed to investigate the potential functions of NAT10 in this context, with a particular focus on its interactions and mechanisms involving ferroptosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, immunohistochemistry, immunofluorescence, and Western blotting were utilized to evaluate the changes of NAT10 and ferroptosis-related marker proteins. Plasmid vectors were utilized to establish stable ccRCC cell lines with NAT10 overexpression and knockdown. Cell proliferation, scratch, and invasion assays were conducted to assess the impact of NAT10 modification on cell proliferation and migration capabilities. Meanwhile, remodelin hydrobromide (HBr) treatment was given to ccRCC cells to observe the variations in cell proliferation ability and ferroptosis marker proteins.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our study demonstrated that NAT10 can enhance the malignant biological behavior of ccRCC, while simultaneously inhibiting markers associated with ferroptosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Therefore, this study suggests that NAT10 may exert a pro-cancer effect by modulating the nuclear factor erythroid-2, like-1(NFE2L1)-glutathione peroxidase-4(GPX4)signaling pathway in ccRCC, indicating its potential as a new therapeutic target for this malignancy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.7717\/peerj.20224","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:21:46Z","timestamp":1761898906000},"page":"e20224","source":"Crossref","is-referenced-by-count":4,"title":["NAT10 inhibits ferroptosis and promotes the progression of renal clear cell carcinoma by regulating the NFE2L1-GPX4 signaling pathway"],"prefix":"10.7717","volume":"13","author":[{"given":"Chao","family":"Tan","sequence":"first","affiliation":[{"name":"Department of Urology, Hebei Medical University, Shijiazhuang, Hebei, China"},{"name":"Department of Urology, Xingtai People\u2019s Hospital, Xingtai, Hebei, China"},{"name":"Department of Cell Laboratory, Hebei Provincial Key Laboratory of Portal Hypertension and Cirrhosis,  Xingtai, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine, Xingtai People\u2019s Hospital, Xingtai, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XinJie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology, Xingtai People\u2019s Hospital, Xingtai, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZiKang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, Xingtai People\u2019s Hospital, Xingtai, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubo","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Urology, Hebei Medical University, Shijiazhuang, Hebei, China"},{"name":"Department of Urology, Xingtai People\u2019s Hospital, Xingtai, Hebei, China"},{"name":"Department of Cell Laboratory, Hebei Provincial Key Laboratory of Portal Hypertension and Cirrhosis,  Xingtai, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4443","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"issue":"5","key":"10.7717\/peerj.20224\/ref-1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3390\/genes13050851","article-title":"A novel cuproptosis-related prognostic gene signature and validation of differential expression in clear cell renal cell carcinoma","volume":"13","author":"Bian","year":"2022","journal-title":"Genes"},{"issue":"9","key":"10.7717\/peerj.20224\/ref-2","doi-asserted-by":"publisher","first-page":"1003914","DOI":"10.3389\/fmed.2022.1003914","article-title":"Establishment of a ccRCC patient-derived chick chorioallantoic membrane model for drug testing","volume":"6","author":"Charbonneau","year":"2022","journal-title":"Frontiers in Medicine"},{"issue":"32","key":"10.7717\/peerj.20224\/ref-3","doi-asserted-by":"publisher","first-page":"e2302705","DOI":"10.1002\/advs.202302705","article-title":"NAT10\/ac4C\/FOXP1 promotes malignant progression and facilitates immunosuppression by reprogramming glycolytic metabolism in cervical cancer","volume":"10","author":"Chen","year":"2023","journal-title":"Advanced Science"},{"key":"10.7717\/peerj.20224\/ref-4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41418-022-01051-7","article-title":"SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma","volume":"30","author":"Chen","year":"2023","journal-title":"Cell Death & Differentiation"},{"issue":"19","key":"10.7717\/peerj.20224\/ref-5","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1056\/NEJMoa2212851","article-title":"Cabozantinib plus Nivolumab and Ipilimumab in renal-cell carcinoma","volume":"388","author":"Choueiri","year":"2023","journal-title":"The New England Journal of Medicine"},{"issue":"8","key":"10.7717\/peerj.20224\/ref-6","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1056\/NEJMoa2106391","article-title":"Adjuvant Pembrolizumab after nephrectomy in renal-cell carcinoma","volume":"385","author":"Choueiri","year":"2021","journal-title":"The New England Journal of Medicine"},{"issue":"8","key":"10.7717\/peerj.20224\/ref-7","doi-asserted-by":"publisher","first-page":"186","DOI":"10.31083\/j.fbl2808186","article-title":"Disulfiram\/copper induce ferroptosis in triple-negative breast cancer cell line MDA-MB-231","volume":"28","author":"Chu","year":"2023","journal-title":"Frontiers in Bioscience"},{"issue":"9","key":"10.7717\/peerj.20224\/ref-8","doi-asserted-by":"publisher","first-page":"e1045","DOI":"10.1002\/ctm2.1045","article-title":"NAT10: an RNA cytidine transferase regulates fatty acid metabolism in cancer cells","volume":"12","author":"Dalhat","year":"2022","journal-title":"Clinical and Translational Medicine"},{"key":"10.7717\/peerj.20224\/ref-9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13045-020-01016-8","article-title":"Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells","volume":"14","author":"Ding","year":"2021","journal-title":"Journal of Hematology & Oncology"},{"issue":"6","key":"10.7717\/peerj.20224\/ref-10","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","article-title":"The cell biology of ferroptosis","volume":"25","author":"Dixon","year":"2024","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"10.7717\/peerj.20224\/ref-11","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1186\/s12885-023-11649-w","article-title":"Yttrium oxide nanoparticles induce cytotoxicity, genotoxicity, apoptosis, and ferroptosis in the human triple-negative breast cancer MDA-MB-231 cells","volume":"23","author":"Emad","year":"2023","journal-title":"BMC Cancer"},{"issue":"12","key":"10.7717\/peerj.20224\/ref-12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.semcancer.2019.07.013","article-title":"Recent insights into apoptosis and toxic autophagy: the roles of MDA-7\/IL-24, a multidimensional anti-cancer therapeutic","volume":"66","author":"Emdad","year":"2020","journal-title":"Seminars in Cancer Biology"},{"issue":"11","key":"10.7717\/peerj.20224\/ref-13","doi-asserted-by":"publisher","first-page":"e2118646119","DOI":"10.1073\/pnas.2118646119","article-title":"Ferroptosis regulation by the NGLY1\/NFE2L1 pathway","volume":"119","author":"Forcina","year":"2022","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.7717\/peerj.20224\/ref-14","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41392-022-01046-3","article-title":"Autophagy, and ferroptosis, and pyroptosis and necroptosis in tumor immunotherapy","volume":"7","author":"Gao","year":"2022","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"42","key":"10.7717\/peerj.20224\/ref-15","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.1038\/s41388-022-02460-1","article-title":"ISCA2 inhibition decreases HIF and induces ferroptosis in clear cell renal carcinoma","volume":"41","author":"Green","year":"2022","journal-title":"Oncogene"},{"issue":"11","key":"10.7717\/peerj.20224\/ref-16","doi-asserted-by":"publisher","first-page":"e7283","DOI":"10.1002\/cam4.7283","article-title":"Remodelin delays non-small cell lung cancer progression by inhibiting NAT10 via the EMT pathway","volume":"13","author":"Guo","year":"2024","journal-title":"Cancer Medicine"},{"issue":"23","key":"10.7717\/peerj.20224\/ref-17","doi-asserted-by":"publisher","first-page":"101470","DOI":"10.1016\/j.molmet.2022.101470","article-title":"Ferroptosis and ferritinophagy in diabetes complications","volume":"60","author":"He","year":"2022","journal-title":"Molecular Metabolism"},{"key":"10.7717\/peerj.20224\/ref-18","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s13046-022-02551-7","article-title":"Acetyltransferase NAT10 regulates the Wnt\/\u03b2-catenin signaling pathway to promote colorectal cancer progression via ac4C acetylation of KIF23 mRNA","volume":"41","author":"Jin","year":"2022","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"8","key":"10.7717\/peerj.20224\/ref-19","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","article-title":"Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy","volume":"12","author":"Koppula","year":"2021","journal-title":"Protein Cell"},{"issue":"13","key":"10.7717\/peerj.20224\/ref-20","doi-asserted-by":"publisher","first-page":"916664","DOI":"10.3389\/fimmu.2022.916664","article-title":"Ferroptosis and autoimmune diseases","volume":"3","author":"Lai","year":"2022","journal-title":"Frontiers in Immunology"},{"issue":"720","key":"10.7717\/peerj.20224\/ref-21","doi-asserted-by":"publisher","first-page":"eadg3049","DOI":"10.1126\/scitranslmed.adg3049","article-title":"Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer","volume":"15","author":"Li","year":"2023","journal-title":"Science Translational Medicine"},{"issue":"12","key":"10.7717\/peerj.20224\/ref-22","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.molcel.2022.03.022","article-title":"Ferroptosis at the intersection of lipid metabolism and cellular signaling","volume":"82","author":"Liang","year":"2022","journal-title":"Molecular Cell"},{"issue":"5","key":"10.7717\/peerj.20224\/ref-23","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41422-023-00793-4","article-title":"Lysine 2-hydroxyisobutyrylation of NAT10 promotes cancer metastasis in an ac4C-dependent manner","volume":"33","author":"Liao","year":"2023","journal-title":"Cell Research"},{"issue":"22","key":"10.7717\/peerj.20224\/ref-24","doi-asserted-by":"publisher","first-page":"7038","DOI":"10.1111\/febs.16059","article-title":"Signaling pathways and defense mechanisms of ferroptosis","volume":"289","author":"Liu","year":"2022","journal-title":"FEBS Journal"},{"issue":"48","key":"10.7717\/peerj.20224\/ref-25","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1038\/s41388-024-03185-z","article-title":"m6A-driven NAT10 translation facilitates fatty acid metabolic rewiring to suppress ferroptosis and promote ovarian tumorigenesis through enhancing ACOT7 mRNA acetylation","volume":"43","author":"Liu","year":"2024","journal-title":"Oncogene"},{"issue":"11","key":"10.7717\/peerj.20224\/ref-26","doi-asserted-by":"publisher","first-page":"5317","DOI":"10.2147\/CMAR.S197733","article-title":"miR-6716-5p promotes metastasis of colorectal cancer through downregulating NAT10 expression","volume":"6","author":"Liu","year":"2019","journal-title":"Cancer Management and Research"},{"issue":"7","key":"10.7717\/peerj.20224\/ref-27","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1093\/nar\/gkaa130","article-title":"Acetylation of MORC2 by NAT10 regulates cell-cycle checkpoint control and resistance to DNA-damaging chemotherapy and radiotherapy in breast cancer","volume":"48","author":"Liu","year":"2020","journal-title":"Nucleic Acids Research"},{"issue":"3","key":"10.7717\/peerj.20224\/ref-28","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/cac2.12523","article-title":"NAT10-mediated ac4C-modified ANKZF1 promotes tumor progression and lymphangiogenesis in clear-cell renal cell carcinoma by attenuating YWHAE-driven cytoplasmic retention of YAP1","volume":"44","author":"Miao","year":"2024","journal-title":"Cancer Communications"},{"issue":"42","key":"10.7717\/peerj.20224\/ref-29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1146\/annurev-nutr-062320-114541","article-title":"Nutritional and metabolic control of ferroptosis","volume":"22","author":"Mishima","year":"2022","journal-title":"Annual Review of Nutrition"},{"issue":"14","key":"10.7717\/peerj.20224\/ref-30","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1056\/NEJMoa2035716","article-title":"Lenvatinib plus Pembrolizumab or Everolimus for advanced renal cell carcinoma","volume":"384","author":"Motzer","year":"2021","journal-title":"The New England Journal of Medicine"},{"key":"10.7717\/peerj.20224\/ref-31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","article-title":"Ferroptosis, a new form of cell death: opportunities and challenges in cancer","volume":"12","author":"Mou","year":"2019","journal-title":"Journal of Hematology & Oncology"},{"issue":"14","key":"10.7717\/peerj.20224\/ref-32","doi-asserted-by":"publisher","first-page":"5459","DOI":"10.7150\/ijbs.74546","article-title":"PHGDH inhibits ferroptosis and promotes malignant progression by upregulating SLC7A11 in bladder cancer","volume":"18","author":"Shen","year":"2022","journal-title":"International Journal of Biological Sciences"},{"issue":"12","key":"10.7717\/peerj.20224\/ref-33","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1161\/CIRCRESAHA.122.322244","article-title":"NAT10 is involved in cardiac remodeling through ac4C-mediated transcriptomic regulation","volume":"133","author":"Shi","year":"2023","journal-title":"Circulation Research"},{"key":"10.7717\/peerj.20224\/ref-34","doi-asserted-by":"publisher","first-page":"13503","DOI":"10.1038\/s41598-022-17755-2","article-title":"A multiomics disease progression signature of low-risk ccRCC","volume":"12","author":"Strauss","year":"2022","journal-title":"Scientific Reports"},{"key":"10.7717\/peerj.20224\/ref-35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41419-025-07528-w","article-title":"NAT10 promotes the progression of clear cell renal cell carcinoma by regulating ac4C acetylation of NFE2L3 and activating AKT\/GSK3\u03b2 signaling pathway","volume":"16","author":"Sun","year":"2025","journal-title":"Cell Death & Disease"},{"key":"10.7717\/peerj.20224\/ref-36","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41585-022-00654-6","article-title":"Fatty acid metabolism reprogramming in ccRCC: mechanisms and potential targets","volume":"20","author":"Tan","year":"2023","journal-title":"Nature Reviews Urology"},{"issue":"4","key":"10.7717\/peerj.20224\/ref-37","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.bbrc.2018.04.047","article-title":"Loss of nucleolar localization of NAT10 promotes cell migration and invasion in hepatocellular carcinoma","volume":"499","author":"Tan","year":"2018","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"5","key":"10.7717\/peerj.20224\/ref-38","doi-asserted-by":"publisher","first-page":"e27084","DOI":"10.1016\/j.heliyon.2024.e27084","article-title":"Pitavastatin induces autophagy-dependent ferroptosis in MDA-MB-231 cells via the mevalonate pathway","volume":"10","author":"Tang","year":"2024","journal-title":"Heliyon"},{"issue":"14","key":"10.7717\/peerj.20224\/ref-39","doi-asserted-by":"publisher","first-page":"e00010-20","DOI":"10.1128\/MCB.00010-20","article-title":"NFE2L1 and NFE2L3 complementarily maintain basal proteasome activity in cancer cells through CPEB3-mediated translational repression","volume":"40","author":"Waku","year":"2020","journal-title":"Molecular and Cellular Biology"},{"issue":"1","key":"10.7717\/peerj.20224\/ref-40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-024-02122-8","article-title":"circASAP1 induces renal clear cell carcinoma ferroptosis by binding to HNRNPC and thereby regulating GPX4","volume":"24","author":"Wang","year":"2025","journal-title":"Molecular Cancer"},{"issue":"5","key":"10.7717\/peerj.20224\/ref-41","doi-asserted-by":"publisher","first-page":"e738","DOI":"10.1002\/ctm2.738","article-title":"NAT10-mediated mRNA N4-acetylcytidine modification promotes bladder cancer progression","volume":"12","author":"Wang","year":"2022","journal-title":"Clinical and Translational Medicine"},{"issue":"11","key":"10.7717\/peerj.20224\/ref-42","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1038\/s41418-022-01008-w","article-title":"Wnt\/beta-catenin signaling confers ferroptosis resistance by targeting GPX4 in gastric cancer","volume":"29","author":"Wang","year":"2022","journal-title":"Cell Death & Differentiation"},{"issue":"8","key":"10.7717\/peerj.20224\/ref-43","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41419-023-06057-8","article-title":"Knockdown of SETD2 promotes erastin-induced ferroptosis in ccRCC","volume":"14","author":"Xue","year":"2023","journal-title":"Cell Death & Disease"},{"issue":"11","key":"10.7717\/peerj.20224\/ref-44","doi-asserted-by":"publisher","first-page":"630417","DOI":"10.3389\/fonc.2021.630417","article-title":"Prognostic and immunological role of mRNA ac4C regulator NAT10 in pan-cancer: new territory for cancer research","volume":"19","author":"Yang","year":"2021","journal-title":"Frontiers in Oncology"},{"issue":"13","key":"10.7717\/peerj.20224\/ref-45","doi-asserted-by":"publisher","first-page":"853822","DOI":"10.3389\/fendo.2022.853822","article-title":"Ferroptosis as a novel therapeutic target for diabetes and its complications","volume":"29","author":"Yang","year":"2022","journal-title":"Frontiers in Endocrinology"},{"issue":"23","key":"10.7717\/peerj.20224\/ref-46","doi-asserted-by":"publisher","first-page":"4352","DOI":"10.1016\/j.molcel.2023.10.042","article-title":"SMURF2 predisposes cancer cell toward ferroptosis in GPX4-independent manners by promoting GSTP1 degradation","volume":"83","author":"Zhang","year":"2023","journal-title":"Molecular Cell"},{"key":"10.7717\/peerj.20224\/ref-47","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in cancer therapy: a novel approach to reversing drug resistance","volume":"21","author":"Zhang","year":"2022","journal-title":"Molecular Cancer"},{"issue":"12","key":"10.7717\/peerj.20224\/ref-48","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/cac2.12363","article-title":"N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA","volume":"42","author":"Zheng","year":"2022","journal-title":"Cancer Communications"},{"issue":"171","key":"10.7717\/peerj.20224\/ref-49","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.freeradbiomed.2021.05.009","article-title":"Verification of ferroptosis and pyroptosis and identification of PTGS2 as the hub gene in human coronary artery atherosclerosis","volume":"1","author":"Zhou","year":"2021","journal-title":"Free Radical Biology and Medicine"},{"issue":"25","key":"10.7717\/peerj.20224\/ref-50","doi-asserted-by":"publisher","first-page":"130155560","DOI":"10.1016\/j.phymed.2024.155560","article-title":"Quercetin inhibits neuronal Ferroptosis and promotes immune response by targeting lipid metabolism-related gene PTGS2 to alleviate breast cancer-related depression","volume":"23","author":"Zhu","year":"2024","journal-title":"Phytomedicine"}],"container-title":["PeerJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/peerj.com\/articles\/20224.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/20224.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/20224.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/20224.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:21:49Z","timestamp":1761898909000},"score":1,"resource":{"primary":{"URL":"https:\/\/peerj.com\/articles\/20224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":50,"alternative-id":["10.7717\/peerj.20224"],"URL":"https:\/\/doi.org\/10.7717\/peerj.20224","archive":["CLOCKSS","LOCKSS","Portico"],"relation":{},"ISSN":["2167-8359"],"issn-type":[{"value":"2167-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"article-number":"e20224"}}